Japanese gastric cancer treatment guidelines 2014 (ver. 4) Japanese Gastric Cancer Association Special Article Open access 24 June 2016 Pages: 1 - 19
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 Giovanni De ManzoniDaniele MarrelliFranco Roviello Special Article 02 June 2016 Pages: 20 - 30
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? Felice PasiniAnna Paola FracconGiovanni de Manzoni Review Article 27 August 2016 Pages: 31 - 42
Comparison the sixth and seventh editions of the AJCC staging system for T1 gastric cancer: a long-term follow-up study of 2124 patients Kyung Hak ChoiByung Sik KimBeom Su Kim Original Article 05 January 2016 Pages: 43 - 48
Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis Ulrich GullerIgnazio TarantinoRene Warschkow Original Article 09 December 2015 Pages: 49 - 60
Relationship between socioeconomic status and accessibility for endoscopic resection among gastric cancer patients: using National Health Insurance Cohort in Korea: poverty and endoscopic resection Na Yeon KimJun Seok OhEun-Cheol Park Original Article 16 February 2016 Pages: 61 - 69
Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study Massimiliano BissolatiMatteo DesioElena Orsenigo Original Article 05 January 2016 Pages: 70 - 82
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival Hans Anton SchlößerUta DrebberHakan Alakus Original Article 07 December 2015 Pages: 83 - 91
Site-specific fibroblasts regulate site-specific inflammatory niche formation in gastric cancer Anna AbeAkiko Kawano NagatsumaAtsushi Ochiai Original Article 22 December 2015 Pages: 92 - 103
Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis Kang-Jin ParkSung-Bum ChoYoung-Eun Joo Original Article 12 January 2016 Pages: 104 - 115
CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β Bert KindlundÅsa SjölingSamuel B. Lundin Original Article 18 January 2016 Pages: 116 - 125
Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer Katsutoshi ShodaDaisuke IchikawaEigo Otsuji Original Article 13 February 2016 Pages: 126 - 135
Epigenetic inactivation of FAT4 contributes to gastric field cancerization Satoshi YoshidaSatoshi YamashitaToshikazu Ushijima Original Article 20 January 2016 Pages: 136 - 145
Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer Jae Ho JeongSook Ryun ParkYoon-Koo Kang Original Article 29 December 2015 Pages: 146 - 155
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy Riccardo GiampieriElena MaccaroniStefano Cascinu Original Article 21 January 2016 Pages: 156 - 163
Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer Chan-Young OckAh-Rong NamDo-Youn Oh Original Article 17 December 2015 Pages: 164 - 174
Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy Kohei ShitaraKeisho ChinToshimasa Tsujinaka Original Article 01 December 2015 Pages: 175 - 181
Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer Shinkyo YoonChanghoon YooYoon-Koo Kang Original Article 11 December 2015 Pages: 182 - 189
Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial Yasuhiro KoderaNaoto TakahashiJunichi Sakamoto Original Article 15 February 2016 Pages: 190 - 199
Effects of administration of a proton pump inhibitor before endoscopic submucosal dissection for differentiated early gastric cancer with ulcer Yu Sik MyungSu Jin HongMoon Sung Lee Original Article 11 December 2015 Pages: 200 - 206
Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving antithrombotic therapy Tsukasa FuruhataMitsuru KaiseToshifumi Mitani Original Article 11 January 2016 Pages: 207 - 214
Tumor-associated macrophages in gastric cancer: more than bystanders in tumor microenvironment Armando RojasFernando Delgado-LópezIleana Gonzalez Letter to the Editor 19 February 2016 Pages: 215 - 216